Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DOW | LEN |
|---|---|---|
| Price | $27.29 | $81.72 |
| Change today | ▼ 0.93% | ▲ 0.16% |
| Market cap | $19.71B | $19.69B |
| Return, 3 months | +2.1% | -5.6% |
| Return, year to date | +20.6% | -19.3% |
| Return, 1 year | +24.1% | -35.0% |
| P/E (TTM) | -14.9 | 15.5 |
| P/B | 1.2 | 0.9 |
| P/E percentile vs own 5y | 11th | 100th |
| Dividend yield | 5.13% | 2.45% |
| Revenue growth (YoY, latest qtr) | +19.7% | -8.7% |
| Net profit growth (YoY) | +200.1% | -52.4% |
| Gross margin | 9.9% | 13.8% |
| Operating margin | 3.7% | 5.6% |
| Net margin | -3.1% | 4.1% |
| Return on equity | -7.9% | 5.9% |
| Analyst target vs. price | +27.2% | -3.1% |
| Analyst buy share | 33% | 8% |
| RSI (14) | 35 | 49 |
| 30-day volatility | 30.2% | 35.8% |
| Max drawdown, 1 year | -34.8% | -41.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
